HYPOLIPIDEMIC EFFECT «SIMVAGLYZINE»
Description and properties
New preparation with hypolipidemic effect is a molecular complex of simvastatine and β-glycyrrhizic acid with molar ratio 1:(1-4).
The given complex is characterized by a reduced toxic effect due to a decreased doze of statine, with therapeutic properties being high.
Low-toxic medication; decrease of effective medical doze; simplicity of production; low price in comparison with the analogues (2-3 times lower).
Patent of the Russian Federation № 2308947 "Medication with hypolipidemic effect "Simvaglizine"
Delivery of pilot batch and technical support in testing process. Cooperation in organization of industrial production.
N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry,
Siberian Branch of the Russian Academy of Sciences
9, Acad. Lavrentiev Ave, 630090, Novosibirsk, 90, Russsia
PhD. N. F. Salakhutdinov, Head of the Department